Do long-term resolution of immunological graft rejection after a dexamethasone intravitreal implant?
In 4 eyes with an immunologic graft rejection after penetrating keratoplasty, the dexamethasone 0.7 mg intravitreal implant was an effective treatment option, even in cases refractory to standard topical and systemic therapy.
LVSR should aim to provide a more physiological shape (conical) rather than simple VR.